Neurostimulation Devices for the Treatment of Neurologic Disorders

Christine A. Edwards, Abbas Kouzani, Kendall H Lee, Erika K. Ross

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Rapid advancements in neurostimulation technologies are providing relief to an unprecedented number of patients affected by debilitating neurologic and psychiatric disorders. Neurostimulation therapies include invasive and noninvasive approaches that involve the application of electrical stimulation to drive neural function within a circuit. This review focuses on established invasive electrical stimulation systems used clinically to induce therapeutic neuromodulation of dysfunctional neural circuitry. These implantable neurostimulation systems target specific deep subcortical, cortical, spinal, cranial, and peripheral nerve structures to modulate neuronal activity, providing therapeutic effects for a myriad of neuropsychiatric disorders. Recent advances in neurotechnologies and neuroimaging, along with an increased understanding of neurocircuitry, are factors contributing to the rapid rise in the use of neurostimulation therapies to treat an increasingly wide range of neurologic and psychiatric disorders. Electrical stimulation technologies are evolving after remaining fairly stagnant for the past 30 years, moving toward potential closed-loop therapeutic control systems with the ability to deliver stimulation with higher spatial resolution to provide continuous customized neuromodulation for optimal clinical outcomes. Even so, there is still much to be learned about disease pathogenesis of these neurodegenerative and psychiatric disorders and the latent mechanisms of neurostimulation that provide therapeutic relief. This review provides an overview of the increasingly common stimulation systems, their clinical indications, and enabling technologies.

Original languageEnglish (US)
Pages (from-to)1427-1444
Number of pages18
JournalMayo Clinic Proceedings
Volume92
Issue number9
DOIs
StatePublished - Sep 1 2017

Fingerprint

Nervous System Diseases
Equipment and Supplies
Electric Stimulation
Psychiatry
Technology
Therapeutics
Spinal Nerves
Cranial Nerves
Therapeutic Uses
Peripheral Nerves
Neuroimaging
Neurodegenerative Diseases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Neurostimulation Devices for the Treatment of Neurologic Disorders. / Edwards, Christine A.; Kouzani, Abbas; Lee, Kendall H; Ross, Erika K.

In: Mayo Clinic Proceedings, Vol. 92, No. 9, 01.09.2017, p. 1427-1444.

Research output: Contribution to journalReview article

Edwards, Christine A. ; Kouzani, Abbas ; Lee, Kendall H ; Ross, Erika K. / Neurostimulation Devices for the Treatment of Neurologic Disorders. In: Mayo Clinic Proceedings. 2017 ; Vol. 92, No. 9. pp. 1427-1444.
@article{5e29a22998da4c20913c9486b345ef73,
title = "Neurostimulation Devices for the Treatment of Neurologic Disorders",
abstract = "Rapid advancements in neurostimulation technologies are providing relief to an unprecedented number of patients affected by debilitating neurologic and psychiatric disorders. Neurostimulation therapies include invasive and noninvasive approaches that involve the application of electrical stimulation to drive neural function within a circuit. This review focuses on established invasive electrical stimulation systems used clinically to induce therapeutic neuromodulation of dysfunctional neural circuitry. These implantable neurostimulation systems target specific deep subcortical, cortical, spinal, cranial, and peripheral nerve structures to modulate neuronal activity, providing therapeutic effects for a myriad of neuropsychiatric disorders. Recent advances in neurotechnologies and neuroimaging, along with an increased understanding of neurocircuitry, are factors contributing to the rapid rise in the use of neurostimulation therapies to treat an increasingly wide range of neurologic and psychiatric disorders. Electrical stimulation technologies are evolving after remaining fairly stagnant for the past 30 years, moving toward potential closed-loop therapeutic control systems with the ability to deliver stimulation with higher spatial resolution to provide continuous customized neuromodulation for optimal clinical outcomes. Even so, there is still much to be learned about disease pathogenesis of these neurodegenerative and psychiatric disorders and the latent mechanisms of neurostimulation that provide therapeutic relief. This review provides an overview of the increasingly common stimulation systems, their clinical indications, and enabling technologies.",
author = "Edwards, {Christine A.} and Abbas Kouzani and Lee, {Kendall H} and Ross, {Erika K.}",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.mayocp.2017.05.005",
language = "English (US)",
volume = "92",
pages = "1427--1444",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "9",

}

TY - JOUR

T1 - Neurostimulation Devices for the Treatment of Neurologic Disorders

AU - Edwards, Christine A.

AU - Kouzani, Abbas

AU - Lee, Kendall H

AU - Ross, Erika K.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Rapid advancements in neurostimulation technologies are providing relief to an unprecedented number of patients affected by debilitating neurologic and psychiatric disorders. Neurostimulation therapies include invasive and noninvasive approaches that involve the application of electrical stimulation to drive neural function within a circuit. This review focuses on established invasive electrical stimulation systems used clinically to induce therapeutic neuromodulation of dysfunctional neural circuitry. These implantable neurostimulation systems target specific deep subcortical, cortical, spinal, cranial, and peripheral nerve structures to modulate neuronal activity, providing therapeutic effects for a myriad of neuropsychiatric disorders. Recent advances in neurotechnologies and neuroimaging, along with an increased understanding of neurocircuitry, are factors contributing to the rapid rise in the use of neurostimulation therapies to treat an increasingly wide range of neurologic and psychiatric disorders. Electrical stimulation technologies are evolving after remaining fairly stagnant for the past 30 years, moving toward potential closed-loop therapeutic control systems with the ability to deliver stimulation with higher spatial resolution to provide continuous customized neuromodulation for optimal clinical outcomes. Even so, there is still much to be learned about disease pathogenesis of these neurodegenerative and psychiatric disorders and the latent mechanisms of neurostimulation that provide therapeutic relief. This review provides an overview of the increasingly common stimulation systems, their clinical indications, and enabling technologies.

AB - Rapid advancements in neurostimulation technologies are providing relief to an unprecedented number of patients affected by debilitating neurologic and psychiatric disorders. Neurostimulation therapies include invasive and noninvasive approaches that involve the application of electrical stimulation to drive neural function within a circuit. This review focuses on established invasive electrical stimulation systems used clinically to induce therapeutic neuromodulation of dysfunctional neural circuitry. These implantable neurostimulation systems target specific deep subcortical, cortical, spinal, cranial, and peripheral nerve structures to modulate neuronal activity, providing therapeutic effects for a myriad of neuropsychiatric disorders. Recent advances in neurotechnologies and neuroimaging, along with an increased understanding of neurocircuitry, are factors contributing to the rapid rise in the use of neurostimulation therapies to treat an increasingly wide range of neurologic and psychiatric disorders. Electrical stimulation technologies are evolving after remaining fairly stagnant for the past 30 years, moving toward potential closed-loop therapeutic control systems with the ability to deliver stimulation with higher spatial resolution to provide continuous customized neuromodulation for optimal clinical outcomes. Even so, there is still much to be learned about disease pathogenesis of these neurodegenerative and psychiatric disorders and the latent mechanisms of neurostimulation that provide therapeutic relief. This review provides an overview of the increasingly common stimulation systems, their clinical indications, and enabling technologies.

UR - http://www.scopus.com/inward/record.url?scp=85028987604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028987604&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2017.05.005

DO - 10.1016/j.mayocp.2017.05.005

M3 - Review article

C2 - 28870357

AN - SCOPUS:85028987604

VL - 92

SP - 1427

EP - 1444

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 9

ER -